Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Raffles Medical GroupRAFLF 57 5-Year Yield-on-Cost % is 3.76 as of Jul. 22, 2026, which is 51% above its 10-year median of 2.49. GuruFocus rates RAFLF with a GF Score™ of 57/100 and a GF Value™ of $0.75 (Fairly Valued). The stock has 4 warning signs investors should review. Among 277 Healthcare Providers & Services companies, Raffles Medical Group ranks better than 61.37% on this metric.
Raffles Medical Group's yield on cost for the quarter that ended in Dec. 2025 was 3.76.
The historical rank and industry rank for Raffles Medical Group's 5-Year Yield-on-Cost % or its related term are showing as below:
RAFLF'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.37 Med: 2.49 Max: 5.56
Current: 3.76
During the past 13 years, Raffles Medical Group's highest Yield on Cost was 5.56. The lowest was 1.37. And the median was 2.49.
RAFLF's 5-Year Yield-on-Cost % is ranked better than 61.37% of 277
companies
in the Healthcare Providers & Services industry
Industry Median: 2.93
vs RAFLF: 3.76
Raffles Medical Group (OTCPK:RAFLF) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Raffles Medical Group 5-Year Yield-on-Cost % Related Terms
RAFLF vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Raffles Medical Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raffles Medical Group 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Raffles Medical Group's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Raffles Medical Group's 5-Year Yield-on-Cost % falls into.
Raffles Medical Group 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Raffles Medical Group (RAFLF) has a 5-Year Yield-on-Cost % of 3.76 as of Jul. 22, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Raffles Medical Group and its competitors. This is 51% above median its historical median of 2.49. Over the past decade, Raffles Medical Group's 5-Year Yield-on-Cost % has ranged from 1.37 to 5.56. According to the industry distribution chart, Raffles Medical Group ranks #107 out of 277 companies in the Healthcare Providers & Services industry, placing it in the top 38.6%.
Is Raffles Medical Group's 5-Year Yield-on-Cost % too high?
Raffles Medical Group's current 5-Year Yield-on-Cost % of 3.76 is 51% above median its 10-year median of 2.49. Over the past 10 years, this metric has ranged from a low of 1.37 to a high of 5.56. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.93. Raffles Medical Group's value of 3.76 is 28.3% above this industry median. Based on the distribution chart, Raffles Medical Group ranks #107 out of 277 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Raffles Medical Group has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Raffles Medical Group's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Raffles Medical Group ranks #107 out of 277 companies for 5-Year Yield-on-Cost %. This puts Raffles Medical Group in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.93. Raffles Medical Group's value of 3.76 is 28.3% above this benchmark. Historically, Raffles Medical Group's own 5-Year Yield-on-Cost % has ranged from 1.37 to 5.56 over the past decade. While the company's 10-year median is 2.49 vs. the industry median of 2.93, Raffles Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.93, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Raffles Medical Group's current 5-Year Yield-on-Cost % of 3.76 is 28.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Raffles Medical Group and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Raffles Medical Group's current 5-Year Yield-on-Cost % is 3.76, which is 51% above median its own 10-year median of 2.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raffles Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Raffles Medical Group (RAFLF) is currently considered Fairly Valued. The stock's GF Value™ is $0.75, compared to a current price of $0.75 — trading 0.4% above its estimated fair value. The current 5-Year Yield-on-Cost % is 3.76, which is 51% above median its 10-year median of 2.49 and 28.3% above the Healthcare Providers & Services industry median of 2.93. Raffles Medical Group's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Raffles Medical Group (RAFLF), the current 5-Year Yield-on-Cost % is 3.76 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Raffles Medical Group (RAFLF) Overvalued in 2026?
Based on GuruFocus' analysis, Raffles Medical Group stock appears to be overvalued.
The current stock price of $0.75 is trading 0.4% above its estimated GF Value™ of $0.75.
GuruFocus considers Raffles Medical Group to be Fairly Valued.
Key valuation signals for RAFLF:
5-Year Yield-on-Cost %: 3.76 (51% above median its 10-year median of 2.49)
GF Value™: $0.75 vs. price of $0.75 (0.4% above fair value)
Industry Position: 28.3% above the Healthcare Providers & Services median (#107 of 277)
No single metric tells the full story. See the RAFLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The company's operating segment includes Healthcare services, Hospital Services, Investment Holdings, and Insurance Services. The company generates revenue from contracts with customers, Rental Income, and Insurance revenue. Geographically operates in Singapore, Greater China, Vietnam, Cambodia and Japan.
57GF Score
Get the complete analysis for RAFLF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RAFLF has been successfully added to your 
